Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Short-acting tablet taken before meals to cut post-meal sugar spikes. | Once-daily sulfonylurea. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | Meglitinides | Sulfonylureas |
| Supply | Prescription only | Prescription only |
| Main uses | Type 2 diabetes | Type 2 diabetes |
| How it works | Boosts insulin briefly around meals. | Releases more insulin from the pancreas. |
| Starts working | 30 minutes | — |
| Half-life | About 1 hour | 5–8 hours |
| Typical adult dose | 0.5 mg before each main meal, adjusted up to 4 mg per dose (maximum 16 mg a day). | 1–4 mg once a day with breakfast (maximum 6–8 mg). |
| Forms | Tablet | Tablet, Combination tablets with metformin |
| Common side effects | Low blood sugar, Stomach upset, Weight gain | Low blood sugar, Weight gain, Dizziness |
| Serious side effects | Severe low blood sugar | Severe hypoglycaemia |
| Don't take if | Type 1 diabetes or ketoacidosis; Severe liver disease; Taking gemfibrozil | Type 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas |
| Alcohol | Best to limit. Alcohol raises the risk of low blood sugar. | Best to limit. Alcohol raises the risk of severe low blood sugar. |
| Pregnancy | Usually avoidedInsulin is preferred in pregnancy. | Usually avoidedSwitch to insulin. |
| Breastfeeding | Usually avoidedNot recommended. | Usually avoidedAvoid; insulin preferred. |
| In use since | — | 1995 |
| Brand names | United States: PrandinUnited Kingdom: NovoNormIndia: Eurepa, Novonorm | United States: AmarylUnited Kingdom: AmarylIndia: Amaryl, Glimy, Glimestar, Gemer (with metformin) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A10BX02 | A10BB12 |
Taken together
- MinorRepaglinide + Glimepiride: More risk of low blood sugar
Both medicines lower blood sugar; combinations are common but hypos become more likely.